Quantbot Technologies LP boosted its stake in National Health Investors, Inc. (NYSE:NHI - Free Report) by 515.3% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,659 shares of the real estate investment trust's stock after buying an additional 19,814 shares during the quarter. Quantbot Technologies LP owned approximately 0.05% of National Health Investors worth $1,640,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also modified their holdings of NHI. Zimmer Partners LP purchased a new stake in shares of National Health Investors during the third quarter worth $25,218,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of National Health Investors by 332.0% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 242,326 shares of the real estate investment trust's stock valued at $20,370,000 after buying an additional 186,238 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of National Health Investors by 17.0% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 852,377 shares of the real estate investment trust's stock valued at $71,651,000 after buying an additional 123,596 shares in the last quarter. Waterfront Capital Partners LLC acquired a new position in National Health Investors in the third quarter worth approximately $10,097,000. Finally, Principal Financial Group Inc. raised its position in National Health Investors by 5.3% during the fourth quarter. Principal Financial Group Inc. now owns 1,648,499 shares of the real estate investment trust's stock valued at $114,242,000 after acquiring an additional 82,825 shares in the last quarter. 62.51% of the stock is currently owned by hedge funds and other institutional investors.
National Health Investors Stock Performance
NYSE:NHI traded up $0.95 during midday trading on Friday, reaching $74.74. The stock had a trading volume of 124,248 shares, compared to its average volume of 214,891. The stock has a market capitalization of $3.41 billion, a P/E ratio of 25.68, a PEG ratio of 4.42 and a beta of 1.08. National Health Investors, Inc. has a 1-year low of $57.80 and a 1-year high of $86.13. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The firm's fifty day simple moving average is $70.84 and its 200-day simple moving average is $74.41.
National Health Investors (NYSE:NHI - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.03. The business had revenue of $85.75 million during the quarter, compared to analysts' expectations of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. On average, equities research analysts forecast that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, May 2nd. Investors of record on Monday, March 31st will be given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a yield of 4.82%. The ex-dividend date of this dividend is Monday, March 31st. National Health Investors's dividend payout ratio (DPR) is presently 115.38%.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on NHI. Truist Financial increased their price target on shares of National Health Investors from $70.00 to $76.00 and gave the stock a "hold" rating in a research note on Wednesday, March 19th. Wedbush restated an "outperform" rating and set a $88.00 target price on shares of National Health Investors in a report on Monday, March 17th. Three research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, National Health Investors currently has an average rating of "Hold" and an average price target of $85.50.
Get Our Latest Research Report on National Health Investors
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
